The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response said today it has awarded a $1.8 million contract to OraSure Technologies Inc., in Bethlehem, PA, to develop an Ebola virus diagnostic test for use in a doctor’s office, hospital, clinic or field setting that will provide results within 20 minutes. Called the OraQuick rapid Ebola antigen test, HHS said the lateral-flow test will detect the presence of a virus with a drop of the patient’s blood or saliva on a test strip, similar to tests used in doctors’ offices to diagnose strep throat. The contract could be extended for up to 39 months and $10.4 million.

Related News Articles

Headline
The World Health Organization on Sunday declared the end of the most recent outbreak of Ebola virus in the Democratic Republic of the Congo, the eighth in the…
Headline
The World Health Organization is investigating an Ebola outbreak in a remote northern area of the Democratic Republic of the Congo, the eighth in the African…
Headline
Mobilizing a rapid and robust clinical research program to explore whether investigational therapeutics and vaccines are safe and effective to combat the next…
Headline
Beginning this month, the Centers for Disease Control and Prevention and National Ebola Training & Education Center will offer two free training workshops…
Headline
The Centers for Disease Control and Prevention today issued a proposed rule amending its domestic and foreign quarantine regulations to aid in responding…
Headline
Starting tomorrow, Acting Assistant Secretary for Health Karen DeSalvo, M.D., will transition out of her dual role as national coordinator for health…